A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

MOUNTAIN VIEW, CA / ACCESS Newswire / June 9, 2025 / Pactum, a leading Agentic AI platform for enterprise procurement, today ...

GlobalData reviewed the number of branded medicines whose first reimbursement date fell between 2021 and 2024 in each ...

Alcon posts steady growth in Vision Care and Surgical, with new drug and therapy launches ahead but execution risks persist.

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

In their June 5 report, DBS Group Research analysts Foo Fang Boo and Ling Lee Keng point to the strong year-to-date (ytd) ...

The World Health Organization estimates a surge in new cancer cases to 23.6 million per year by 2030. This alarming projection underscores the urgent need for effective cancer treatments, positioning ...

The World Association for Small and Medium Enterprises (WASME) hosted the highly anticipated International Ambassadors Meet 2025 in partnership with the Embassy of the Federal Democratic Republic of ...

MoonLake Immunotherapeutics shares surged 31% after the Financial Times reported, citing unnamed sources, that the company had rejected an initial acquisition offer by Merck & Co. for more than $3 ...

Otsuka and Vera Therapeutics have both presented new data on drug candidates for IgA nephropathy (IgAN), striving to join a ...

Agentic AI leader Pactum secures US$54m in Series C funding to scale its Negotiation Suite AI platform, which empowers ...